African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
{{output}}
Introduction: Alzheimer's disease (AD) incidence is disproportionately high in African Americans, yet, recruitment of this community to AD clinical trials is challenging. ... ...
